Taken together, these results implicated that up-regulated SNHG16 levels with a concurrent increase in the expression of TLR4 and TRAF6 in PBMCs can participate in SLE activity, resulting in the AH manifestation. This evidence concerns the gene TRAF6 and systemic lupus erythematosus.